Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hohenegger

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
British Journal of Pharmacology|December 1, 1999
Pharmacological activation of the ryanodine receptor in Jurkat T-lymphocytesM Hohenegger, I Berg, L Weigl, et al.
The Journal of Biological Chemistry|October 26, 2000
Inhibition of adenylyl and guanylyl cyclase isoforms by the antiviral drug foscarnetO Kudlacek, T Mitterauer, C Nanoff, et al.
Experimental Pathology|January 1, 1985
Increased serum triacylglycerol and cholesterol binding reserve in acute uremic ratsR Gottlob, A N Srour, H Echsel, et al.
Molecular Pharmacology|April 1, 1996
Suramin analogues as subtype-selective G protein inhibitorsM Freissmuth, S Boehm, W Beindl, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 1998
Gsalpha-selective G protein antagonistsM Hohenegger, M Waldhoer, W Beindl, et al.
Molecular Pharmacology|December 1, 1996
Activation of the skeletal muscle ryanodine receptor by suramin and suramin analogsM Hohenegger, M Matyash, K Poussu, et al.
The International Journal of Artificial Organs|May 1, 1988
Toxicity in uremia. 2. Correlation between PTH levels and impaired aspecific immunityR Esposito, C Romano-Carratelli, N Lanzetti, et al.
The International Journal of Artificial Organs|May 1, 1988
Toxicity in uremia. 1. Correlation between PTH levels and depressed cell proliferationR Esposito, M Manzo, M Hohenegger, et al.
The Journal of Biological Chemistry|December 23, 1994
Species difference in the G protein selectivity of the human and bovine A1-adenosine receptorR Jockers, M E Linder, M Hohenegger, et al.
Klinische Wochenschrift|June 1, 1977
[Patterns of renal and haemodynamic functions in cadaver kidney donors under dopamine (author's transl)]V Draxler, J Krenn, P Sporn, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
British Journal of Pharmacology|December 1, 1999
Pharmacological activation of the ryanodine receptor in Jurkat T-lymphocytesM Hohenegger, I Berg, L Weigl, et al.
The Journal of Biological Chemistry|October 26, 2000
Inhibition of adenylyl and guanylyl cyclase isoforms by the antiviral drug foscarnetO Kudlacek, T Mitterauer, C Nanoff, et al.
Experimental Pathology|January 1, 1985
Increased serum triacylglycerol and cholesterol binding reserve in acute uremic ratsR Gottlob, A N Srour, H Echsel, et al.
Molecular Pharmacology|April 1, 1996
Suramin analogues as subtype-selective G protein inhibitorsM Freissmuth, S Boehm, W Beindl, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 1998
Gsalpha-selective G protein antagonistsM Hohenegger, M Waldhoer, W Beindl, et al.
Molecular Pharmacology|December 1, 1996
Activation of the skeletal muscle ryanodine receptor by suramin and suramin analogsM Hohenegger, M Matyash, K Poussu, et al.
The International Journal of Artificial Organs|May 1, 1988
Toxicity in uremia. 2. Correlation between PTH levels and impaired aspecific immunityR Esposito, C Romano-Carratelli, N Lanzetti, et al.
The International Journal of Artificial Organs|May 1, 1988
Toxicity in uremia. 1. Correlation between PTH levels and depressed cell proliferationR Esposito, M Manzo, M Hohenegger, et al.
The Journal of Biological Chemistry|December 23, 1994
Species difference in the G protein selectivity of the human and bovine A1-adenosine receptorR Jockers, M E Linder, M Hohenegger, et al.
Klinische Wochenschrift|June 1, 1977
[Patterns of renal and haemodynamic functions in cadaver kidney donors under dopamine (author's transl)]V Draxler, J Krenn, P Sporn, et al.
Pageof 11